Several studies have used small-molecule STAT3 inhibitors, such as STA-21/C188-9/Stattic, to suppress STAT3 signaling in different animal models of autoimmune/inflammatory diseases, such as asthma, lupus nephritis, and arthritis [19,20,21]. Here, STAT3 is linked to arthritic joint disease.